Addex Therapeutics (ADXN) Exchange Rate Effect (2019 - 2026)
Addex Therapeutics (ADXN) posted Exchange Rate Effect of -$3.9 billion for Q1 2026, down 120.7% sequentially from $18.8 billion in Q2 2025, and up 77.52% YoY from -$2.2 billion in Q1 2025.
Addex Therapeutics (ADXN) Exchange Rate Effect (2019 - 2026) Analysis & Trends
Addex Therapeutics has reported Exchange Rate Effect for 8 years, with the latest figure at -$3.9 billion in Q1 2026.
- Quarterly Exchange Rate Effect rose 77.52% year-over-year to -$3.9 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$77.7 billion (up 37.77% YoY) and the FY2025 annual result came in at -$42438.8, down 137.45% from the prior year.
- Exchange Rate Effect slipped to -$3.9 billion in Q1 2026 per ADXN's latest filing, from $18.8 billion in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $170.1 billion in Q4 2023 and troughed at -$108.4 billion in Q2 2024.
- A 5-year average of $11.5 billion and a median of -$1088.8 in 2023 frame the typical range for Exchange Rate Effect.
- The widest YoY moves for Exchange Rate Effect: up 25954984817.91% in 2024, down 9951848046.56% in 2024.
- Over 5 years, Exchange Rate Effect stood at -$203920.4 in 2022, then soared by 83425168.87% to $170.1 billion in 2023, then plunged by 144.25% to -$75.3 billion in 2024, then jumped by 124.94% to $18.8 billion in 2025, then plunged by 120.7% to -$3.9 billion in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$3.9 billion, $18.8 billion, and -$17.3 billion for Q1 2026, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Addex Therapeutics | 534.71 Mn | 534.71 Mn | - | -3.88 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.88 Bn |
| Mar 31, 2026 | -3.88 Bn |
| Jun 30, 2025 | 18.77 Bn |
| Jun 30, 2025 | 18.77 Bn |
| Mar 31, 2025 | -17.28 Bn |
| Mar 31, 2025 | -17.28 Bn |
| Dec 31, 2024 | -75.27 Bn |
| Dec 31, 2024 | -75.27 Bn |
| Sep 30, 2024 | 76.11 Bn |
| Sep 30, 2024 | 76.11 Bn |
| Jun 30, 2024 | -108.36 Bn |
| Jun 30, 2024 | -108.36 Bn |
| Mar 31, 2024 | 112.27 Bn |
| Mar 31, 2024 | 112.27 Bn |
| Dec 31, 2023 | 170.12 Bn |
| Dec 31, 2023 | 170.12 Bn |
| Sep 30, 2023 | -293.23 |
| Sep 30, 2023 | -293.23 |
| Jun 30, 2023 | -1,088.82 |
| Jun 30, 2023 | -1,088.82 |